REG - Wellnex Life Limited - Appointment of Storelink as NZ Distributor

Wellnex LifeAnnouncement

18/09/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250918:nRSR8084Za&default-theme=true

RNS Number : 8084Z  Wellnex Life Limited  18 September 2025

 

ASX/AIM
Announcement
18 September 2025

 

Wellnex Life Limited (ASX/AIM:WNX)

 

Wellnex Life secures New Zealand distributor for the Company's expansion of
its innovative brands

 

Highlights

 

·      Wellnex Life appoints leading New Zealand distributor Storelink
(https://www.storelink.co.nz/) to represent the Company's brands in the New
Zealand market

·      Following the Company's Pain Away brand relaunch in Chemist
Warehouse New Zealand last year, Wellnex Life is focused on driving growth
through the New Zealand market with the planned expansion of other brands

·      The appointment of Storelink in New Zealand supports the
Company's strategy to increase awareness of the Company and its brands in
additional regional markets

 

Wellnex Life Limited (ASX/AIM: WNX) (Wellnex Life or Company) is pleased to announce the appointment of Storelink Sales Limited (Storelink) as its distribution partner to take the Company's innovative brands into the New Zealand market.

 

Wellnex Life, on the back of its late 2024 Pain Away brand relaunch in Chemist
Warehouse New Zealand, has identified additional grocery and pharmacy channel
opportunities in the New Zealand market for its brands. Storelink was
identified as the ideal partner for the New Zealand market to help accelerate
the growth of Wellnex Life brands in additional regional markets.

 

Wellnex Life will work closely with and support Storelink to commence
presenting its brands to New Zealand retailers over the coming months, with
sales planned to commence in the first half this financial year.

 

About Storelink

 

Storelink is one of New Zealand's largest full-service retail execution
specialists. For over 35 years, Storelink has helped ambitious FMCG brands get
seen, sold and scaled - everywhere that matters.

 

Tony Puppyn, General Manager of Storelink said: "Storelink is thrilled with
our collaboration with Australian company Wellnex Life. We are eagerly looking
forward to the opportunity to introduce Wellnex Life's exciting and innovative
brands to the New Zealand market. Together, we aim to enhance the well-being
of individuals across New Zealand with Wellnex Life's exceptional products."

 

Zack Bozinovski CEO Wellnex Life said: "We are excited to partner with a
highly experienced and regarded company such as Storelink, to help distribute
our innovative and exciting brands throughout the grocery and pharmacy
channels in New Zealand. The Storelink team demonstrated a strong
understanding of our Company brands and an even stronger alignment to our
distribution objectives. The ability to now have our Australian brands
available in the New Zealand market formed part of Company's strategic focus
post our UK distribution partner announcement earlier this year. The Wellnex
Life team look forward to closely working with Tony and his team to execute
our brand strategy into the New Zealand retailers."

 

To stay up to date on company news and announcements, please register your
details on the Wellnex Life Limited investor portal:
(https://propell.investorportal.com.au/stay-up-to-date/)
https://wellnexlife.investorportal.com.au/register/
(https://wellnexlife.investorportal.com.au/register/)

This ASX/AIM announcement has been authorised by the Board of Wellnex Life
Limited (ASX/AIM:WNX).

For further information, please contact:

 

Wellnex Life Limited (ASX:WNX)
                                 Reach Markets

Zack Bozinovski
                       T: 1300 805 795

Chief Executive Officer & Managing
Director                  E: IR@reachmarkets.com.au
(mailto:IR@reachmarkets.com.au)

P: +61 3 8399 9419

E: zack.b@wellnexlife.com.au (mailto:zack.b@wellnexlife.com.au)

 

UK Investors

 

Strand Hanson (Financial & Nominated Advisor)

James Harris / Richard Johnson
                        Tel: +44 (0) 20 7409 3494

 

Orana Corporate LLP (Joint
Broker)
swykeham@oranacorp.com (mailto:swykeham@oranacorp.com)

Sebastian Wykeham

 

S.P. Angel Corporate Finance LLP (Joint Broker)             Tel: +44
(0)20 3470 0470

David Hignell / Vadim Alexandre

 

About Wellnex Life

 

Wellnex Life Limited (ASX/AIM:WNX) is a consumer healthcare business with a
track record for developing, licensing, and marketing registered products and
brands to customers in the growing healthcare market segment. Since listing on
ASX in 2021, Wellnex Life has successfully launched a host of brands and
products now ranged in major retailers in the healthcare market space,
pharmacies and supermarkets. Its distribution arrangements have seen Wellnex
Life secure significant licensing arrangements with major pharmaceutical
companies in Australia and globally that have given the Company's registered
products a distribution channel with a steadily increasing global geographic
footprint.

In December 2023, Wellnex Life acquired leading Australian topical pain relief
brand Pain Away. Its addition to Wellnex Life's product offering both
compliments and accelerates the potential growth of the company's business
operations. This transformational acquisition gives added impetus to Wellnex
Life's financial growth and scale and reinforces its place as a major and
respected participant in the growing healthcare market, both in Australia and
overseas.

 

To learn more, please visit: www.Wellnex Lifelife.com.au/
(https://wellnexlife.com.au/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKOBBNBKBCCD